Payment overview · 2025
General Payments
$364.91
12 reported records · 11 companies
Healthcare provider profile · identity verified
Thomas Emil Mandat, MD
Allopathic & Osteopathic Physicians|Internal Medicine · PARMA, OH · NPI 1881792794
Verified facts
What the public records show
CMS Open Payments records show Thomas Emil Mandat, MD received $364.91 in general payments during 2025 across 12 reported records.
Mannkind Corporation accounted for 23.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Xifaxan.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Prolia by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 330 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 330 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 120 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 79 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1737 claims for Eliquis by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULANCE as an associated drug or biological on 2652 records involving 1501 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Trulance by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Xifaxan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Mannkind Corporation | Unresolved — no canonical attribution shown | $85.00 | 23.3% | 2 | 2025 |
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$75.82 | 20.8% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $56.16 | 15.4% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $23.68 | 6.5% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $20.89 | 5.7% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $20.28 | 5.6% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $19.62 | 5.4% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $17.62 | 4.8% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $16.87 | 4.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.14 | 4.2% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $13.83 | 3.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $279.91 | 10 |
| Education | $85.00 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AFREZZA Normalized: afrezza |
Drug | Mannkind Corporation | $85.00 | 2 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $56.16 | 1 | 2025 |
Source payment records
|
|||||
| AMYVID Normalized: amyvid |
Drug | Lilly USA, LLC | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| KISUNLA Normalized: kisunla |
Drug | Lilly USA, LLC | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $20.89 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $20.28 | 1 | 2025 |
Source payment records
|
|||||
| VOWST Normalized: vowst |
Biological | Aimmune Therapeutics, Inc. | $19.62 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.62 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.14 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $13.83 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $13.83 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 330 | exact normalized | Medicare Part D |
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 53 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
330 | 37 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
330 | 37 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
93 | 19 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
120 | 20 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
79 | 76 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1737 | 189 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | TRULANCE open payments reported associated product |
CMS Open Payments — General Payments 2652 supporting records · 1501 recipient NPIs · example record 1231775445 |
Trulance · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
53 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3706 | 528 |
| Gabapentin | Gabapentin | 2002 | 276 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1786 | 249 |
| Amlodipine Besylate | Amlodipine Besylate | 1765 | 265 |
| Eliquis | Apixaban | 1737 | 189 |
| Furosemide | Furosemide | 1531 | 271 |
| Potassium Chloride | Potassium Chloride | 1519 | 210 |
| Mirtazapine | Mirtazapine | 1473 | 201 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1466 | 228 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1460 | 235 |
| Lisinopril | Lisinopril | 1256 | 172 |
| Metoprolol Succinate | Metoprolol Succinate | 1136 | 207 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1128 | 210 |
| Trazodone Hcl | Trazodone Hcl | 1092 | 174 |
| Duloxetine Hcl | Duloxetine Hcl | 1037 | 172 |
| Sertraline Hcl | Sertraline Hcl | 1008 | 158 |
| Metformin Hcl | Metformin Hcl | 993 | 151 |
| Omeprazole | Omeprazole | 977 | 194 |
| Donepezil Hcl | Donepezil Hcl | 856 | 92 |
| Escitalopram Oxalate | Escitalopram Oxalate | 844 | 93 |
| Divalproex Sodium | Divalproex Sodium | 813 | 81 |
| Torsemide | Torsemide | 737 | 125 |
| Famotidine | Famotidine | 727 | 95 |
| Losartan Potassium | Losartan Potassium | 699 | 122 |
| Levetiracetam | Levetiracetam | 695 | 83 |
| Clopidogrel | Clopidogrel Bisulfate | 656 | 120 |
| Buspirone Hcl | Buspirone Hcl | 629 | 84 |
| Xarelto | Rivaroxaban | 620 | 61 |
| Carvedilol | Carvedilol | 601 | 96 |
| Prednisone | Prednisone | 583 | 145 |
| Hydralazine Hcl | Hydralazine Hcl | 573 | 93 |
| Allopurinol | Allopurinol | 572 | 89 |
| Baclofen | Baclofen | 562 | 60 |
| Quetiapine Fumarate | Quetiapine Fumarate | 559 | 91 |
| Simvastatin | Simvastatin | 520 | 60 |
| Memantine Hcl | Memantine Hcl | 517 | 48 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 468 | 96 |
| Ondansetron Hcl | Ondansetron Hcl | 461 | 173 |
| Spironolactone | Spironolactone | 387 | 83 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 375 | 145 |
| Doxycycline Hyclate | Doxycycline Hyclate | 349 | 177 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 338 | 52 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 330 | 90 |
| Jardiance | Empagliflozin | 330 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 325 | 42 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 322 | 87 |
| Fluticasone Propionate | Fluticasone Propionate | 319 | 124 |
| Risperidone | Risperidone | 286 | 24 |
| Nystatin | Nystatin | 283 | 111 |
| Myrbetriq | Mirabegron | 277 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 274 | 41 |
| Midodrine Hcl | Midodrine Hcl | 274 | 72 |
| Finasteride | Finasteride | 267 | 56 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 260 | 155 |
| Olanzapine | Olanzapine | 257 | 36 |
| Methylprednisolone | Methylprednisolone | 255 | 156 |
| Montelukast Sodium | Montelukast Sodium | 251 | 39 |
| Albuterol Sulfate | Albuterol Sulfate | 247 | 95 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 246 | 56 |
| Bupropion Xl | Bupropion Hcl | 237 | 35 |
| Latanoprost | Latanoprost | 237 | 50 |
| Glipizide | Glipizide | 236 | 30 |
| Atenolol | Atenolol | 226 | 26 |
| Aripiprazole | Aripiprazole | 220 | 37 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 220 | 34 |
| Levofloxacin | Levofloxacin | 210 | 118 |
| Azithromycin | Azithromycin | 207 | 102 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 200 | 83 |
| Sodium Chloride | 0.9 % Sodium Chloride | 198 | 87 |
| Cephalexin | Cephalexin | 196 | 83 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 186 | 116 |
| Meloxicam | Meloxicam | 185 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 184 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 184 | 27 |
| Farxiga | Dapagliflozin Propanediol | 182 | 23 |
| Lamotrigine | Lamotrigine | 176 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 175 | 85 |
| Amiodarone Hcl | Amiodarone Hcl | 174 | 44 |
| Sucralfate | Sucralfate | 174 | 48 |
| Warfarin Sodium | Warfarin Sodium | 172 | 25 |
| Januvia | Sitagliptin Phosphate | 171 | 23 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 166 | 82 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 163 | 62 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 163 | 35 |
| Digoxin | Digoxin | 162 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 160 | 85 |
| Meclizine Hcl | Meclizine Hcl | 160 | 41 |
| Lubiprostone | Lubiprostone | 159 | 14 |
| Topiramate | Topiramate | 157 | 17 |
| Metoclopramide Hcl | Metoclopramide Hcl | 155 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 154 | 30 |
| Alendronate Sodium | Alendronate Sodium | 151 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 149 | 37 |
| Ezetimibe | Ezetimibe | 146 | 29 |
| Heparin Sodium | Heparin Sodium,porcine | 140 | 43 |
| Enoxaparin Sodium | Enoxaparin Sodium | 138 | 31 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 137 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 137 | 32 |
| Clonidine Hcl | Clonidine Hcl | 136 | 26 |
| Lactulose | Lactulose | 136 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 135 | 26 |
| Ceftriaxone | Ceftriaxone Sodium | 134 | 65 |
| Fluoxetine Hcl | Fluoxetine Hcl | 133 | 31 |
| Humalog Kwikpen U-100 | Insulin Lispro | 131 | 41 |
| Diclofenac Sodium | Diclofenac Sodium | 129 | 45 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 129 | 24 |
| Tradjenta | Linagliptin | 128 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 126 | 18 |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 125 | 30 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 124 | 42 |
| Ozempic | Semaglutide | 120 | 20 |
| Fluconazole | Fluconazole | 118 | 75 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 116 | 27 |
| Primidone | Primidone | 116 | suppressed |
| Glimepiride | Glimepiride | 114 | 31 |
| Propranolol Hcl | Propranolol Hcl | 105 | 20 |
| Sevelamer Carbonate | Sevelamer Carbonate | 103 | 18 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 101 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 96 | 13 |
| Haloperidol | Haloperidol | 93 | 19 |
| Trulicity | Dulaglutide | 93 | 19 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 92 | 42 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 91 | 29 |
| Doxazosin Mesylate | Doxazosin Mesylate | 90 | 23 |
| Brimonidine Tartrate | Brimonidine Tartrate | 88 | 17 |
| Lidocaine | Lidocaine | 88 | 23 |
| Oxcarbazepine | Oxcarbazepine | 88 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 86 | 23 |
| Amantadine | Amantadine Hcl | 85 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 85 | 43 |
| Lidocaine Hcl | Lidocaine Hcl | 83 | 50 |
| Calcitriol | Calcitriol | 82 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 82 | 17 |
| Fenofibrate | Fenofibrate,micronized | 82 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 81 | 28 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 79 | 76 |
| Entresto | Sacubitril/Valsartan | 79 | 14 |
| Bethanechol Chloride | Bethanechol Chloride | 78 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 75 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 75 | 12 |
| Fenofibrate | Fenofibrate | 73 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 72 | 13 |
| Clonidine | Clonidine | 71 | 12 |
| Constulose | Lactulose | 71 | 16 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 71 | 22 |
| Budesonide | Budesonide | 70 | 23 |
| Humalog | Insulin Lispro | 70 | 28 |
| Nitroglycerin | Nitroglycerin | 70 | 38 |
| Hydrocortisone | Hydrocortisone | 69 | 28 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 69 | 32 |
| Amoxicillin | Amoxicillin | 68 | 35 |
| Enulose | Lactulose | 68 | 17 |
| Ketoconazole | Ketoconazole | 68 | 35 |
| Metolazone | Metolazone | 67 | 14 |
| Mupirocin | Mupirocin | 66 | 29 |
| Novolog Flexpen | Insulin Aspart | 66 | 16 |
| Valproic Acid | Valproic Acid | 66 | suppressed |
| Colchicine | Colchicine | 65 | 22 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 65 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 65 | 11 |
| Cholestyramine | Cholestyramine (With Sugar) | 64 | 26 |
| Venlafaxine Hcl | Venlafaxine Hcl | 63 | 12 |
| Sodium Chloride | Sodium Chloride Irrig Solution | 62 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 61 | 17 |
| Ammonium Lactate | Ammonium Lactate | 60 | 32 |
| Ibuprofen | Ibuprofen | 60 | 30 |
| Chlorthalidone | Chlorthalidone | 59 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 58 | 15 |
| Methocarbamol | Methocarbamol | 58 | 22 |
| Celecoxib | Celecoxib | 57 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 57 | suppressed |
| Clozapine | Clozapine | 57 | suppressed |
| Nyamyc | Nystatin | 56 | 33 |
| Timolol Maleate | Timolol Maleate | 56 | 12 |
| Lorazepam | Lorazepam | 55 | 32 |
| Prazosin Hcl | Prazosin Hcl | 55 | suppressed |
| Xifaxan | Rifaximin | 53 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 52 | 14 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 52 | suppressed |
| Insulin Lispro | Insulin Lispro | 52 | 31 |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 52 | 35 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 51 | 13 |
| Meropenem | Meropenem | 51 | 15 |
| Ipratropium Bromide | Ipratropium Bromide | 50 | 12 |
| Kapspargo Sprinkle | Metoprolol Succinate | 50 | suppressed |
| Linzess | Linaclotide | 50 | 11 |
| Rivastigmine | Rivastigmine Tartrate | 50 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 50 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 49 | 38 |
| Clindamycin Hcl | Clindamycin Hcl | 49 | 22 |
| Dicyclomine Hcl | Dicyclomine Hcl | 49 | 15 |
| Glycopyrrolate | Glycopyrrolate | 48 | suppressed |
| Carbamazepine | Carbamazepine | 47 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 47 | suppressed |
| Nystop | Nystatin | 47 | 29 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 46 | 46 |
| Cimetidine | Cimetidine | 46 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 46 | suppressed |
| Scopolamine | Scopolamine | 46 | 16 |
| Trintellix | Vortioxetine Hydrobromide | 46 | suppressed |
| Dexamethasone | Dexamethasone | 45 | 28 |
| Lacosamide | Lacosamide | 45 | suppressed |
| Lansoprazole | Lansoprazole | 45 | suppressed |
| Ursodiol | Ursodiol | 45 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 44 | 12 |
| Klor-Con | Potassium Chloride | 43 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 42 | suppressed |
| Jantoven | Warfarin Sodium | 42 | suppressed |
| Ranolazine Er | Ranolazine | 42 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 41 | 23 |
| Dorzolamide Hcl | Dorzolamide Hcl | 41 | 11 |
| Humulin R | Insulin Regular, Human | 41 | 11 |
| Ondansetron Odt | Ondansetron | 41 | 21 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 40 | suppressed |
| Lovastatin | Lovastatin | 40 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 40 | 17 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | suppressed |
| Nifedipine Er | Nifedipine | 39 | suppressed |
| Pregabalin | Pregabalin | 39 | suppressed |
| Anastrozole | Anastrozole | 38 | suppressed |
| Erythromycin | Erythromycin Base | 38 | 16 |
| Incruse Ellipta | Umeclidinium Bromide | 38 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 38 | 16 |
| Sodium Chloride | Sodium Chloride 0.45 % | 37 | 19 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | suppressed |
| Metronidazole | Metronidazole | 36 | 15 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 36 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 36 | 17 |
| Spiriva Handihaler | Tiotropium Bromide | 36 | suppressed |
| Brilinta | Ticagrelor | 35 | suppressed |
| Calcium Acetate | Calcium Acetate | 35 | suppressed |
| Daptomycin | Daptomycin | 35 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 35 | suppressed |
| Hydroxyurea | Hydroxyurea | 35 | suppressed |
| Erythromycin Ethylsuccinate | Erythromycin Ethylsuccinate | 34 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 34 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 34 | suppressed |
| Vraylar | Cariprazine Hcl | 34 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 34 | 11 |
| Acetic Acid | Acetic Acid | 33 | 11 |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 33 | 12 |
| Gentamicin Sulfate | Gentamicin Sulfate | 33 | 13 |
| Naproxen | Naproxen | 33 | suppressed |
| Rytary | Carbidopa/Levodopa | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | 11 |
| Clonazepam | Clonazepam | 32 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 12 |
| Gemfibrozil | Gemfibrozil | 31 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 31 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 31 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 31 | suppressed |
| Mirabegron Er | Mirabegron | 30 | 11 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 29 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 29 | 16 |
| Creon | Lipase/Protease/Amylase | 29 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 29 | 15 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 29 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 29 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 29 | suppressed |
| Phenytoin | Phenytoin | 29 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 28 | suppressed |
| Famotidine | Famotidine/Pf | 28 | suppressed |
| Linezolid | Linezolid | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Procrit | Epoetin Alfa | 28 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 28 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 27 | suppressed |
| Neupro | Rotigotine | 27 | suppressed |
| Trospium Chloride | Trospium Chloride | 27 | suppressed |
| Galantamine Er | Galantamine Hbr | 26 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 26 | suppressed |
| Valsartan | Valsartan | 26 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 25 | 12 |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | suppressed |
| Azathioprine | Azathioprine | 24 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Klayesta | Nystatin | 23 | 15 |
| Moxifloxacin | Moxifloxacin Hcl | 23 | 14 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | 14 |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 22 | suppressed |
| Cefazolin Sodium-Dextrose | Cefazolin Sodium/Dextrose,iso | 22 | suppressed |
| Cholestyramine Light | Cholestyramine | 22 | suppressed |
| Gemtesa | Vibegron | 22 | suppressed |
| Mounjaro | Tirzepatide | 22 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 22 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Clotrimazole | Clotrimazole | 21 | suppressed |
| Fluocinonide | Fluocinonide | 21 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 21 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 21 | 15 |
| Trifluoperazine Hcl | Trifluoperazine Hcl | 21 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 20 | suppressed |
| Austedo Xr | Deutetrabenazine | 20 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 20 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 20 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 20 | 11 |
| Haloperidol Decanoate | Haloperidol Decanoate | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 20 | 15 |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Ciclopirox | Ciclopirox | 19 | suppressed |
| Folic Acid | Folic Acid | 19 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | 17 |
| Alphagan P | Brimonidine Tartrate | 18 | suppressed |
| Dalfampridine Er | Dalfampridine | 18 | suppressed |
| Glucagon Emergency Kit | Glucagon | 18 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Tobramycin | Tobramycin | 18 | 16 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 18 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Mesalamine Er | Mesalamine | 17 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 17 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 17 | 12 |
| Acetylcysteine | Acetylcysteine | 16 | suppressed |
| Alprazolam | Alprazolam | 16 | suppressed |
| Niacin Er | Niacin | 16 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 16 | suppressed |
| Xiidra | Lifitegrast | 16 | suppressed |
| Zosyn | Piperacillin-Tazo-Dextrose,iso | 16 | suppressed |
| Acarbose | Acarbose | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Pentoxifylline | Pentoxifylline | 15 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Cefdinir | Cefdinir | 14 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Entacapone | Entacapone | 14 | suppressed |
| Ertapenem | Ertapenem Sodium | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 14 | suppressed |
| Rifampin | Rifampin | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Aztreonam | Aztreonam | 13 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 13 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 13 | suppressed |
| Perphenazine | Perphenazine | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Acetazolamide Er | Acetazolamide | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Trulance | Plecanatide | 12 | suppressed |
| Alogliptin | Alogliptin Benzoate | 11 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Pramipexole Er | Pramipexole Di-Hcl | 11 | suppressed |
| Prolia | Denosumab | 11 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 11 | suppressed |
| Soaanz | Torsemide | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 11 | suppressed |
| Trimethoprim | Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $364.91 · 12 records | Mannkind Corporation | AFREZZA, AMYVID, Dexcom G6 Transmitter, INGREZZA, JARDIANCE, KISUNLA, NURTEC ODT, PAXLOVID, REPATHA, VOWST, XIFAXAN | 10 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error